• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Establishment of the platform for a drug discovery of multiple myeloma by targeting PBK-related signaling pathway

Research Project

Project/Area Number 21K08426
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 54010:Hematology and medical oncology-related
Research InstitutionKinjo Gakuin University (2023)
Aichi Medical University (2021-2022)

Principal Investigator

Ota Akinobu  金城学院大学, 生活環境学部, 教授 (30438048)

Co-Investigator(Kenkyū-buntansha) 武井 則雄  北海道大学, 医学研究院, 助教 (50523461)
花村 一朗  愛知医科大学, 医学部, 教授 (70440740)
シバスンダラン カルナン  愛知医科大学, 医学部, 講師 (30557096)
Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2023: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2022: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2021: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords多発性骨髄腫 / 悪性化 / 治療標的分子 / 細胞生物学 / 薬剤スクリーニング / PBK / ゲノム異常 / 分子病態 / セルベースアッセイ / 創薬 / ノックアウトマウス
Outline of Research at the Start

多発性骨髄腫(骨髄腫)は、多様なDNAの異常が病気の発症・進展に関わる難治性疾患である。本研究ではPDZ-binding kinase (PBK)を標的とした創薬を目指すために、PBKノックアウトマウスの表現型解析、薬剤スクリーニングによるPBKを標的とした新たな化合物の探索、新規MM悪性化分子の機能解析をおこなう。さらに、PBK阻害剤による抗腫瘍効果の解析と、次世代シーケンサーによる遺伝子(発現)異常の解析をおこなうことにより、PBKと骨髄腫の分子病態との連関を解明する。本研究は、難治性骨髄腫の新たな分子病態の解明に基づいた創薬を主眼としており、その波及効果は極めて高い。

Outline of Final Research Achievements

Multiple myeloma (MM) is an incurable plasma cell hematological malignancy. This study is aimed to precisely elucidate the molecular pathology related to the malignant transformation of MM. We have identified malignant factors from the gene group induced by Interleukin-6, analyzed the gene functions, and attempted to identify new therapeutic agents. Here, we conducted drug screening, identified novel malignant factors located in the 1q genomic amplification region, and analyzed the properties of PBK knockout mice to verify the potential of PBK and related molecules as therapeutic targets. The results revealed that (1) PBK expression is related tothe sensitivity of immunomodulatory drug, (2) a novel malignant factor enhances DNA repair ability in MM cells, and (3) PBK knockout mice do not exhibit any major phenotypes. These results strongly suggest that inhibition of PBK may lead to the development of novel therapeutic agents that suppress the malignant transformation of MM.

Academic Significance and Societal Importance of the Research Achievements

多発性骨髄腫(Multiple myeloma、以下MM)は、形質細胞性の難治性血液悪性腫瘍である。現在の医療では、MMの再発や悪性化を完全に抑制することは難しく、MM悪性化の克服はMM患者の更なるQOL延伸に向けた喫緊の課題である。本研究は、遺伝子発現解析をもとにMMの悪性化に関わる分子機構の解析を試み、MMの新たな治療標的分子PBKに関する治療応用の可能性を検証したものであり、学術的・社会的意義は極めて高い。解析の結果、PBKの喪失は、マウスに顕著な表現型を示さない一方、一部のMM細胞に対する薬剤感受性に影響を及ぼすことから、PBKを標的とした分子標的薬開発は有望である可能性が示唆された。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (28 results)

All 2024 2023 2022 2021 Other

All Int'l Joint Research (1 results) Journal Article (17 results) (of which Int'l Joint Research: 12 results,  Peer Reviewed: 17 results,  Open Access: 17 results) Presentation (6 results) Book (2 results) Patent(Industrial Property Rights) (2 results)

  • [Int'l Joint Research] ワシントン大学(シアトル)(米国)

    • Related Report
      2023 Annual Research Report
  • [Journal Article] Leucine zipper protein 1 (LUZP1) regulates the constriction velocity of the contractile ring during cytokinesis.2024

    • Author(s)
      Hyodo T, Asano-Inami E, Ito S, Sugiyama M, Nawa A, Rahman ML, Hasan MN, Mihara Y, Lam VQ, Karnan S, Ota A, Tsuzuki S, Hamaguchi M, Hosokawa Y, Konishi H.
    • Journal Title

      FEBS J.

      Volume: 291(5) Issue: 5 Pages: 927-944

    • DOI

      10.1111/febs.17017

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells.2024

    • Author(s)
      Karnan S, Hanamura I, Ota A, Vu LQ, Uchino K, Horio T, Murakami S, Mizuno S, Rahman ML, Wahiduzzaman M, Hasan MN, Biswas M, Hyodo T, Ito H, Suzuki A, Konishi H, Tsuzuki S, Hosokawa Y, Takami A.
    • Journal Title

      Cell Death Discov.

      Volume: 10(1):56. Issue: 1 Pages: 56-56

    • DOI

      10.1038/s41420-024-01814-w

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Neurotropin ameliorates chronic pain associated with scar formation in a mouse model: A gene expression analysis of the inflammatory response2024

    • Author(s)
      Zhou Xuan、Iida Hiroki、Li Yugiang、Ota Akinobu、Zhuo Lisheng、Nobuhara Reiko、Terajima Yuki、Naiki Mitsuru、Reddi A. Hari、Kimata Koji、Ushida Takahiro
    • Journal Title

      Molecular Pain

      Volume: ND

    • DOI

      10.1177/17448069241245420

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Flow cytometry-based quantification of genome editing efficiency in human cell lines using the L1CAM gene.2023

    • Author(s)
      Hasan MN, Hyodo T, Biswas M, Rahman ML, Mihara Y, Karnan S, Ota A, Tsuzuki S, Hosokawa Y, Konishi H.
    • Journal Title

      PLoS One.

      Volume: 18(11) Issue: 11 Pages: 16416-16430

    • DOI

      10.1371/journal.pone.0294146

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma2023

    • Author(s)
      Karnan Sivasundaram、Ota Akinobu、Murakami Hideki、Rahman Md. Lutfur、Wahiduzzaman Md、Hasan Muhammad Nazmul、Vu Lam Quang、Hanamura Ichiro、Inoko Akihito、Riku Miho、Ito Hideaki、Kaneko Yoshifumi、Hyodo Toshinori、Konishi Hiroyuki、Tsuzuki Shinobu、Hosokawa Yoshitaka
    • Journal Title

      Cell Death Discovery

      Volume: 9 Issue: 1 Pages: 257-257

    • DOI

      10.1038/s41420-023-01552-5

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Inhibition of VEGFR2 and EGFR signaling cooperatively suppresses the proliferation of oral squamous cell carcinoma.2023

    • Author(s)
      Onda M, Ota A, Ito K, Ono T, Karnan S, Kato M, Kondo S, Furuhashi A, Hayashi T, Hosokawa Y, Kazaoka Y.
    • Journal Title

      Cancer Med.

      Volume: 12(15) Issue: 15 Pages: 16416-16430

    • DOI

      10.1002/cam4.6282

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] <scp>PDZ</scp> ‐binding kinase inhibitor <scp>OTS514</scp> suppresses the proliferation of oral squamous carcinoma cells2023

    • Author(s)
      Kato Mikako、Ota Akinobu、Ono Takayuki、Karnan Sivasundaram、Hyodo Toshinori、Rahman Md Lutfur、Hasan Muhammad Nazmul、Onda Maho、Kondo Sayuri、Ito Kunihiro、Furuhashi Akifumi、Hayashi Tomio、Konishi Hiroyuki、Tsuzuki Shinobu、Hosokawa Yoshitaka、Kazaoka Yoshiaki
    • Journal Title

      Oral Diseases

      Volume: in press Issue: 2 Pages: 223-234

    • DOI

      10.1111/odi.14533

    • Related Report
      2023 Annual Research Report 2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Long noncoding RNA profile of the intracranial artery in patients with moyamoya disease2023

    • Author(s)
      Mamiya Takashi、Kanamori Fumiaki、Yokoyama Kinya、Ota Akinobu、Karnan Sivasundaram、Uda Kenji、Araki Yoshio、Maesawa Satoshi、Yoshikawa Kazuhiro、Saito Ryuta
    • Journal Title

      Journal of Neurosurgery

      Volume: 138 Issue: 3 Pages: 709-716

    • DOI

      10.3171/2022.5.jns22579

    • Related Report
      2023 Annual Research Report 2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] PBK Enhances Cellular Proliferation With Histone H3 Phosphorylation and Suppresses Migration and Invasion With CDH1 Stabilization in Colorectal Cancer2022

    • Author(s)
      Koshino Akira、Nagano Aya、Ota Akinobu、Hyodo Toshinori、Ueki Akane、Komura Masayuki、Sugimura-Nagata Akane、Ebi Masahide、Ogasawara Naotaka、Kasai Kenji、Hosokawa Yoshitaka、Kasugai Kunio、Takahashi Satoru、Inaguma Shingo
    • Journal Title

      Frontiers in Pharmacology

      Volume: 12 Pages: 772926-772935

    • DOI

      10.3389/fphar.2021.772926

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Correction of a CD55 mutation to quantify the efficiency of targeted knock-in via flow cytometry2022

    • Author(s)
      Rahman Md. Lutfur、Hyodo Toshinori、Hasan Muhammad Nazmul、Mihara Yuko、Karnan Sivasundaram、Ota Akinobu、Tsuzuki Shinobu、Hosokawa Yoshitaka、Konishi Hiroyuki
    • Journal Title

      Molecular Biology Reports

      Volume: - Issue: 7 Pages: 6241-6248

    • DOI

      10.1007/s11033-022-07422-0

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] BCL6 inhibition ameliorates resistance to ruxolitinib in &lt;i&gt;CRLF2&lt;/i&gt;-rearranged acute lymphoblastic leukemia2022

    • Author(s)
      Tsuzuki Shinobu、Yasuda Takahiko、Goto Hiroaki、Maeda Naoko、Akahane Koshi、Inukai Takeshi、Yamamoto Hideyuki、Karnan Sivasundaram、Ota Akinobu、Hyodo Toshinori、Konishi Hiroyuki、Hosokawa Yoshitaka、Kiyoi Hitoshi、Hayakawa Fumihiko
    • Journal Title

      Haematologica

      Volume: 108 Issue: 2 Pages: 394-408

    • DOI

      10.3324/haematol.2022.280879

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Clostridium butyricum-induced ω-3 fatty acid 18-HEPE elicits anti-influenza virus pneumonia effects through interferon-λ upregulation2022

    • Author(s)
      Hagihara Mao、Yamashita Makoto、Ariyoshi Tadashi、Eguchi Shuhei、Minemura Ayaka、Miura Daiki、Higashi Seiya、Oka Kentaro、Nonogaki Tsunemasa、Mori Takeshi、Iwasaki Kenta、Hirai Jun、Shibata Yuichi、Umemura Takumi、Kato Hideo、Asai Nobuhiro、Yamagishi Yuka、Ota Akinobu、Takahashi Motomichi、Mikamo Hiroshige
    • Journal Title

      Cell Reports

      Volume: 41 Issue: 11 Pages: 111755-111755

    • DOI

      10.1016/j.celrep.2022.111755

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] PBK expression predicts favorable survival in colorectal cancer patients2021

    • Author(s)
      Nagano-Matsuo A, Inoue S, Koshino A, Ota A, Nakao K, Komura M, Kato H, Naiki-Ito A, Watanabe K, Nagayasu Y, Hosokawa Y, Takiguchi S, Kasugai K, Kasai K, Inaguma S, Takahashi S
    • Journal Title

      Virchows Archiv

      Volume: - Issue: 2 Pages: 277-284

    • DOI

      10.1007/s00428-021-03062-0

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells2021

    • Author(s)
      Yusuke Azami, Naohiro Tsuyama, Yu Abe, Misaki Sugai-Takahashi, Ken-Ichi Kudo, Akinobu Ota, Karnan Sivasundaram , Moe Muramatsu, Tomonari Shigemura, Megumi Sasatani, Yuko Hashimoto, Shigehira Saji, Kenji Kamiya, Ichiro Hanamura, Takayuki Ikezoe, Masafumi Onodera, Akira Sakai.
    • Journal Title

      Sci Rep

      Volume: 11 Issue: 1 Pages: 5216-5216

    • DOI

      10.1038/s41598-021-84628-5

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia2021

    • Author(s)
      Karnan Sivasundaram、Hanamura Ichiro、Uchino Kaori、Murakami Satsuki、Wahiduzzaman Md、Quang Vu Lam、Rahman Md Lutfur、Hasan Muhammad Nazmul、Hyodo Toshinori、Konishi Hiroyuki、Tsuzuki Shinobu、Yoshikawa Kazuhiro、Suzuki Susumu、Ueda Ryuzo、Ejiri Masayuki、Hosokawa Yoshitaka、Takami Akiyoshi
    • Journal Title

      Cell Death Discovery

      Volume: 7 Issue: 1 Pages: 1-10

    • DOI

      10.1038/s41420-021-00446-8

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Transcriptome-wide analysis of intracranial artery in patients with moyamoya disease showing upregulation of immune response, and downregulation of oxidative phosphorylation and DNA repair2021

    • Author(s)
      Kanamori Fumiaki、Yokoyama Kinya、Ota Akinobu、Yoshikawa Kazuhiro、Karnan Sivasundaram、Maruwaka Mikio、Shimizu Kenzo、Ota Shinji、Uda Kenji、Araki Yoshio、Okamoto Sho、Maesawa Satoshi、Wakabayashi Toshihiko、Natsume Atsushi
    • Journal Title

      Neurosurgical Focus

      Volume: 51 Issue: 3 Pages: E3-E3

    • DOI

      10.3171/2021.6.focus20870

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Flow cytometry-based quantification of targeted knock-in events in human cell lines using a GPI-anchor biosynthesis gene <i>PIGP</i>2021

    • Author(s)
      Rahman Md.?Lutfur、Hyodo Toshinori、Hasan Muhammad?Nazmul、Mihara Yuko、Karnan Sivasundaram、Ota Akinobu、Tsuzuki Shinobu、Hosokawa Yoshitaka、Konishi Hiroyuki
    • Journal Title

      Bioscience Reports

      Volume: 41 Issue: 12

    • DOI

      10.1042/bsr20212231

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] PBK阻害剤OTS514は口腔扁平上皮癌細胞においてE2F標的遺伝子の下方制御と細胞増殖を抑制する2023

    • Author(s)
      太田 明伸、カルナン シバスンラダン、小西 裕之、都築 忍、細川 好孝、風岡 宜暁
    • Organizer
      第82回日本癌学会学術総会
    • Related Report
      2023 Annual Research Report
  • [Presentation] LUZP1, a novel CPC colocalizing protein, regulates the constriction velocity of the contractile ring during cytokinesis.2023

    • Author(s)
      Toshinori Hyodo, Muhammad Nazmul Hasan, Mrityunjoy Biswas, Eri Inami, Sivasundaram Karnan, Akinobu Ota, Shinobu Tsuzuki, Yoshitaka Hosokawa, Hiroyuki Konishi.
    • Organizer
      第46回日本分子生物学会
    • Related Report
      2023 Annual Research Report
  • [Presentation] A Rapid and Sensitive FCM-Based Assay for Monitoring CRISPR/Cas9 Genome Editing in L1CAM Gene2023

    • Author(s)
      Muhammad Nazmul Hasan, Toshinori Hyodo, Mrityunjoy Biswas, Md. Lutfur Rahman, Yuko Mihara, Sivasundaram Karnan, Akinobu Ota, Shinobu Tsuzuki, Yoshitaka Hosokawa, and Hiroyuki Konishi
    • Organizer
      第46回日本分子生物学会
    • Related Report
      2023 Annual Research Report
  • [Presentation] Targeting MEF2D-fusion Oncogenic Transcriptional Circuitries in B-cell Precursor Acute Lymphoblastic Leukemia2022

    • Author(s)
      Shinobu Tsuzuki, Takahiko Yasuda, Masahito Kawazu, Toshihide Ueno, Sivasundaram Karnan, Akinobu Ota, Masashi Sanada, Hirokazu Nagai, Akihiro Tomita, Yoshiyuki Takahashi, Yasushi Miyazaki, Itaru Matsumura, Hitoshi Kiyoi, Yoshitaka Hosokawa, Hiroyuki Mano, Fumihiko Hayakawa
    • Organizer
      日本癌学会
    • Related Report
      2022 Research-status Report
  • [Presentation] ゲノム編集法を用いた不死化ヒト中皮細胞株の形質転換に関わる分子機構の解析と悪性中皮腫に対する新規治療標的分子の探索2021

    • Author(s)
      太田 明伸、シバスンダラン カルナン、細川 好孝
    • Organizer
      第2回日本石綿・中皮腫学会学術集会
    • Related Report
      2021 Research-status Report
  • [Presentation] Tandem paired nicking法による高精度でDNA損傷反応を誘起しない塩基置換の特性解析2021

    • Author(s)
      小西裕之, 兵頭寿典, Md. Lutfur Rahman, Muhammad Nazmul Hasan, 三原 優子, Sivasundaram Karnan, 太田 明伸, 都築 忍, 細川 好孝. Tandem paired nicking法による高精度でDNA損傷反応を誘起しない塩基置換の特性解析
    • Organizer
      日本ゲノム編集学会第6回大会
    • Related Report
      2021 Research-status Report
  • [Book] ゲノム編集技術~実験上のポイント/産業利用に向けた研究開発動向と安全性周知2023

    • Author(s)
      立川 雅司、畑田 出穂、藤井 渉
    • Total Pages
      315
    • Publisher
      情報機構
    • ISBN
      9784865022421
    • Related Report
      2022 Research-status Report
  • [Book] Toxicological Risk Assessment and Multi-System Health Impacts from Exposure 1st edition2021

    • Author(s)
      Ekhtear Hossain, Md Wahiduzzaman, Akinobu Ota
    • Total Pages
      684
    • Publisher
      Elsevier
    • ISBN
      9780323853583
    • Related Report
      2021 Research-status Report
  • [Patent(Industrial Property Rights)] RAS遺伝子変異体癌治療薬2022

    • Inventor(s)
      シバスンダラン カルナン、太田 明伸、花村 一朗、細川 好孝
    • Industrial Property Rights Holder
      シバスンダラン カルナン、太田 明伸、花村 一朗、細川 好孝
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2022-169541
    • Filing Date
      2022
    • Related Report
      2022 Research-status Report
  • [Patent(Industrial Property Rights)] 悪性中皮腫の治療薬2021

    • Inventor(s)
      シバスンダラン カルナン、太田 明伸、細川 好孝
    • Industrial Property Rights Holder
      シバスンダラン カルナン、太田 明伸、細川 好孝
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2021-169563
    • Filing Date
      2021
    • Related Report
      2021 Research-status Report

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi